Ms. Rachel Fan

Chief Executive Officer

 

Ms. Rachel Fan comes from a strong multinational pharmaceutical (Novartis, Burroughs Wellcome, SmithKline Beecham, and later GlaxoSmithKline “GSK”) background. She previously held key positions in many cross Asia Pacific countries’ business development, sales, and marketing departments. 

​

Rachel’s previous contribution between 2006 and 2015 in GSK was mainly in the company’s strategic leadership role and as an Innovative Business unit director in driving innovative new product launches and market shares uptake. Ten out of the 15 new product launches became market leaders (audited HKAPI industry sales reports) in the product category in less than three years. 

​

During her tenure in the leadership role, Rachel has also obtained numerous company local and regional marketing excellence awards and regional leadership awards consecutively between 2008 to 2013 and was also identified as a local talent since 2008 for the company to further invest and develop, e.g. through leadership program in the Asia Pacific region and the UK headquarter. 

​

Rachel continued her passion for medical innovative products and started her own genetic testing service company in 2015, from which she has successfully gained a leading sales position in pediatric genetic testing and diagnostic whole-exome sequencing in academic medical institutions. To date, she has delivered over 90% net profit return on investment in 4 years. Rachel joined GBL in April 2020 to realize her passion further in innovative microbiome medicine.